229 hedge funds and large institutions have $2.48B invested in Insmed in 2023 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 88 increasing their positions, 72 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

0.78% more ownership

Funds ownership: 105.88%106.65% (+0.78%)

13% less capital invested

Capital invested by funds: $2.86B → $2.48B (-$384M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
229
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.64M
Puts
$7.08M
Net Calls
Net Calls Change

Top Buyers

1 +$38.1M
2 +$19.4M
3 +$8.51M
4
Citadel Advisors
Citadel Advisors
Florida
+$8.3M
5
IC
Ikarian Capital
Texas
+$8.27M

Top Sellers

1 -$25.8M
2 -$17.5M
3 -$17M
4
N
Nuveen
North Carolina
-$12M
5
AG
Artal Group
Luxembourg
-$9.99M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$1.65M
102
$1.59M
103
$1.44M
104
$1.4M
105
$1.37M
106
$1.33M
107
$1.32M
108
$1.3M
109
$1.23M
110
$1.22M
111
$1.21M
112
$1.21M
113
$1.18M
114
$1.14M
115
$1.13M
116
$1.12M
117
$1.12M
118
$1.11M
119
$1.07M
120
$1.07M
121
$1.04M
122
$1.02M
123
$950K
124
$940K
125
$858K